FTSE MIB
34.272,39 +332,64 (+0,98%) Dow Jones
38.085,80 -375,12 (-0,98%) Nasdaq
15.611,76 -100,99 (-0,64%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
84,13 +0,56 (+0,67%) Bitcoin EUR
59.822,32 +374,62 (+0,63%)
DSS, Inc. (DSS)
Dopo ore:
| Chiusura precedente | 1,8000 |
| Aperto | 1,8400 |
| Denaro | 0,0000 x 900 |
| Lettera | 0,0000 x 2200 |
| Min-Max giorno | 1,7400 - 1,8400 |
| Intervallo di 52 settimane | 1,6450 - 9,3600 |
| Volume | |
| Media Volume | 11.022 |
| Capitalizzazione | 12,402M |
| Beta (5 anni mensile) | 1,69 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -11,5200 |
| Prossima data utili | 13 mag 2024 - 17 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 27,60 |
GlobeNewswireDSS Inc. Issues Letter to Shareholders
CEO Highlights Expected IPO of Impact Biomedical and Progress in SubsidiariesROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders, On behalf of the management team at DSS, Inc., I am pleased to provi
GlobeNewswireDSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed IncomeROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has joined as Chief Operating Officer and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role of Portfolio Ma
- GlobeNewswire
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc.ROCHESTER, N.Y., July 31, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs to shareholders, announced today the distribution date for the previously announced stock dividend of Impact
